<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Frank</forename><surname>Weidemann</surname></persName>
							<email>f.weidemann@katharinen-hospital.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Innere Klinik II</orgName>
								<orgName type="institution" key="instit2">Katharinen-Hospital</orgName>
								<address>
									<settlement>Unna</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sebastian</forename><forename type="middle">K G</forename><surname>Maier</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">II. Medizinische Klinik</orgName>
								<orgName type="institution" key="instit2">Klinikum Straubing GmbH</orgName>
								<address>
									<settlement>Straubing</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Stefan</forename><surname>Störk</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Brunner</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD b</roleName><forename type="first">Dan</forename><surname>Liu</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD b ,</roleName><forename type="first">Kai</forename><surname>Hu</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD b</roleName><forename type="first">Nora</forename><surname>Seydelmann</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD b ,</roleName><forename type="first">Andreas</forename><surname>Schneider</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jan</forename><surname>Becher</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">II. Medizinische Klinik</orgName>
								<orgName type="institution" key="instit2">Klinikum Straubing GmbH</orgName>
								<address>
									<settlement>Straubing</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD d ,</roleName><forename type="first">Sima</forename><surname>Canan-Kühl</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Medical Divi-sion, Nephrology and Cardiology</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum</addrLine>
									<settlement>Charité, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD d ,</roleName><forename type="first">Daniela</forename><surname>Blaschke</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Medical Divi-sion, Nephrology and Cardiology</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum</addrLine>
									<settlement>Charité, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Bart</forename><surname>Bijnens</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Catalan Institution for Research and Advanced Studies</orgName>
								<orgName type="institution">Universitat Pompeu Fabra</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country>Spain. Manuscript</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD b</roleName><forename type="first">Georg</forename><surname>Ertl</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD b</roleName><forename type="first">Christoph</forename><surname>Wanner</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Peter</forename><surname>Nordbeck</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Comprehensive Heart Failure Center</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">1BD9FD0AC1CF2C4878343ED9003DE78E</idno>
					<idno type="DOI">10.1016/j.amjcard.2016.04.033</idno>
					<note type="submission">received January 29, 2016; revised manuscript received and accepted April 26, 2016. Drs. Weidemann and Maier contributed equally.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:50+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Patients with genetic cardiomyopathy that involves myocardial hypertrophy often develop clinically relevant arrhythmias that increase the risk of sudden death.</s><s>Consequently, guidelines for medical device therapy were established for hypertrophic cardiomyopathy, but not for conditions with only anecdotal evidence of arrhythmias, like Fabry cardiomyopathy.</s><s>Patients with Fabry cardiomyopathy progressively develop myocardial fibrosis, and sudden cardiac death occurs regularly.</s><s>Because 24-hour Holter electrocardiograms (ECGs) might not detect clinically important arrhythmias, we tested an implanted loop recorder for continuous heart rhythm surveillance and determined its impact on therapy.</s><s>This prospective study included 16 patients (12 men) with advanced Fabry cardiomyopathy, relevant hypertrophy, and replacement fibrosis in "loco typico."</s><s>No patients previously exhibited clinically relevant arrhythmias on Holter ECGs.</s><s>Patients received an implantable loop recorder and were prospectively followed with telemedicine for a median of 1.2 years (range 0.3 to 2.0 years).</s><s>The primary end point was a clinically meaningful event, which required a therapy change, captured with the loop recorder.</s><s>Patients submitted data regularly (14 -11 times per month).</s><s>During follow-up, 21 events were detected (including 4 asystole, i.e., ECG pauses ‡3 seconds) and 7 bradycardia events; 5 episodes of intermittent atrial fibrillation (&gt;3 minutes) and 5 episodes of ventricular tachycardia (3 sustained and 2 nonsustained).</s><s>Subsequently, as defined in the primary end point, 15 events leaded to a change of therapy.</s><s>These patients required therapy with a pacemaker or cardioverteredefibrillator implantation and/or anticoagulation therapy for atrial fibrillation.</s><s>In conclusion, clinically relevant arrhythmias that require further device and/or medical therapy are often missed with Holter ECGs in patients with advanced stage Fabry cardiomyopathy, but they can be detected by telemonitoring with an implantable loop recorder.</s><s>Ó 2016 The Authors.</s><s>Published by Elsevier Inc.</s><s>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).</s><s>(Am J Cardiol 2016;118:264e274) Fabry disease is an X-linked lysosomal storage disorder that results from a deficiency in alpha-galactosidase A. <ref type="bibr" target="#b0">1</ref> The cardiac pathogenetic correlate is the accumulation of globotriaosylceramides in cells, which causes left ventricular (LV) hypertrophy and finally leads to myocardial replacement fibrosis.</s><s><ref type="bibr">1e7</ref> In these fibrotic hearts, life-threatening arrhythmias can develop. <ref type="bibr" target="#b7">8</ref></s><s>Thus, patients at risk should be evaluated regularly for potential arrhythmia treatments.</s><s>The current recommendations <ref type="bibr" target="#b8">9</ref> for managing patients with confirmed Fabry disease include an annual Holter electrocardiogram (ECG) assessment to detect different types of advanced arrhythmias that indicate a potential need to switch therapy.</s><s>The Holter ECG covers only a relatively short period; therefore, it might be beneficial to implement continuous surveillance for potential arrhythmias in patients at high risk for severe arrhythmias.</s><s>Several implantable devices are available for continuous rhythm surveillance, such as the Reveal XT device (Medtronic, Minneapolis, Minnesota).</s><s>These devices reliably facilitate the detection of cardiac arrhythmias in routine clinical care. <ref type="bibr" target="#b9">10</ref></s><s>However, the role of these devices in improving the detection of relevant cardiac arrhythmias that require a change in clinical management, such as ventricular tachycardia (VT), bradycardia, and atrial fibrillation (AF), remains to be determined in patients with Fabry disease.</s><s>Therefore, the present study aimed to investigate whether an implantable loop recorder with telemonitoring capabilities could reveal events that required a change in clinical management in patients at risk of developing clinically relevant arrhythmias associated with advanced Fabry cardiomyopathy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>Study recruitment started in June 2012 and ended in September 2014.</s><s>A total of 120 consecutive patients with Fabry cardiomyopathy were screened in the Fabry centers in Würzburg and Berlin.</s><s>Criteria for inclusion were (1) genetically proved Fabry disease, (2) signs of severe LV fibrosis (defined in the following section), (3) no previous detectable clinically relevant arrhythmia (defined in the following section) on Holter ECG, (4) stable treatment with enzyme replacement therapy for at least 12 months, and (5) informed consent for examinations and participation in the study.</s><s>All these criteria had to be met for enrollment in the study.</s><s>Exclusion criteria were (1) anticoagulation treatment due to AF, (2) an implanted pacemaker or cardioverteredefibrillator (ICD), and (3) signs of AF or VT in the past.</s></p><p><s>Severe fibrosis was defined as the presence of at least 2 segments of late enhancement (LE) during cardiac magnetic resonance imaging (cMRI) or wall motion abnormalities combined with wall thinning in at least 2 LV segments after exclusion of coronary artery disease (CAD) with heart catheterization.</s><s>In all patients with signs or symptoms of CAD (i.e., by a stress test), a heart catheterization was performed to rule out CAD.</s><s>We defined a clinically relevant arrhythmia as (1) bradycardia with a heart rate 40 beats/ min during the day, which indicated a need for pacing therapy; (2) an electrical ventricular pause !3 seconds during the day, which indicated a need for pacing therapy;</s></p><p><s>(3) sustained (&gt;30 seconds) or symptomatic nonsustained (&lt;30 seconds) VT, which indicated a need for an ICD; or (4) AF that lasted at least 3 minutes, which indicated a need for anticoagulation. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b12">12</ref></s><s>f the 120 patients screened, 22 fulfilled the inclusion criteria, and 6 refused to participate.</s><s>Consequently, this prospective study included 16 consecutive patients (4 women) who were considered "at risk" of developing clinically relevant arrhythmias.</s><s>At baseline, before loop recorder implantation, an echocardiography, cMRI (when not contraindicated), Holter ECG, and clinical assessment were performed in all patients.</s><s>A yearly follow-up was conducted with the same assessments performed in the baseline visit.</s><s>All patients were asked to transmit data from the loop recorder by telephone as often as possible.</s><s>The loop recorder was explanted when a patient required implantation of an ICD or pacemaker.</s><s>According to the Declaration of Helsinki, we obtained written informed consent for all patients or their guardians.</s><s>The local institutional ethics board approved the study protocol.</s></p><p><s>We performed LV parasternal long-axis imaging with M-Mode echocardiography (Vivid 7, GE Vingmed Ultrasound AS, Horten, Norway) to determine the end-diastolic septal (interventricular septal wall thickness at end diastole [IVSd]) and posterior wall thicknesses.</s><s>In addition, we measured the left atrial (LA) diameter, and we calculated the LV ejection fraction with Simpson's formula.</s><s>We used blood pool pulsed Doppler of the mitral valve inflow to quantify the ratio of early-to-late (E/A) diastolic flow velocity and the deceleration time.</s><s>The transmitral flow was determined by placing the Doppler window between the tips of the mitral valve leaflets; we measured the peak flow velocities in early (E wave) and late (A wave) systole.</s><s>In addition, tissue Doppler was performed for measuring the ratio between early transmitral flow and peak early tissue Doppler velocity (E/E 0 ).</s><s>Measurements were averaged over 3 cycles.</s></p><p><s>We performed 2-dimensional speckle tracking with an EchoPAC (GE Vingmed Ultrasound AS, Horten, Norway) to acquire standard apical views of the LV for off-line quantification of myocardial deformation.</s><s>After manually selecting the Region of Interest, speckles were applied automatically and then confirmed by the user.</s><s>We used semiautomatic postprocessing to extract the longitudinal systolic strain of the 17 LV segments.</s></p><p><s>We performed cMRI to quantify myocardial mass and cardiac volumes with standard, steady state free precession cine imaging sequences on a 1.5 T whole body scanner (Magnetom Avanto, Siemens Medical Systems, Erlangen, Germany).</s><s>To detect myocardial fibrosis, we acquired delayed enhancement images after an intravenous injection of gadopentetate dimeglumine (0.2 mmol/kg; Magnevist, Schering AG, Berlin, Germany).</s><s>We used a T1-weighted inversion recovery sequence with the breath hold technique (field of view 240 Â 320 mm 2 , matrix size 165 Â 256, slice thickness 8 mm, repetition time 7.5 ms, echo time 3.4 ms, and flip angle 25 ).</s><s>Care was taken to use identical settings in the baseline and follow-up examinations for a given patient.</s><s>All consecutive, short-axis slices covering the whole heart were used to measure the area with pathological LE.</s><s>The sum of areas that showed LE was multiplied by the slice thickness, and then expressed as a percentage of the LV myocardium volume.</s></p><p><s>Twelve-lead surface resting ECGs were recorded at a sweep of 50 mm/s.</s><s>ECGs were measured manually and analyzed by a reader who was blinded to the disease stage.</s><s>Standard criteria for ECG findings were applied, as follows: A normal PR interval was defined as 120 to 200 ms.</s><s>A normal QRS duration was defined as 70 to 110 ms.</s><s>LV hypertrophy was assessed with the SokoloweLyon index, where the S wave in lead V1 or V2 (whichever was larger) was added to the R wave in lead V5 or V6 (whichever was larger), with a minimum cutoff of 3.5 mV.</s><s>The QT interval (normal 300 to 440 ms) was measured from the beginning of the QRS complex to the end of the T wave, which was defined as the point where the tangent to the downslope of the T wave intersected the isoelectric line.</s><s>The corrected QT duration (normal &lt;440 ms) was calculated with the Bazett's formula.</s><s>For negative or biphasic T waves, the peak was measured from the nadir of the T wave.</s><s>ST-segment elevation was defined as a J point elevation that was !2 mm in the precordial leads and !1 mm in the limb leads.</s><s>ST-segment decrease was defined as a J point decrease that was !1.5 mm in the precordial leads and !1 mm in the limb leads.</s></p><p><s>The Holter ECG was started between 8 A.M. and 10 A.M. and continued for a mean of 22.3 hours.</s><s>The data were analyzed by a reader blinded to the disease stage.</s><s>Premature ventricular beats (PVBs) were counted automatically, with manual correction.</s><s>All counts were then corrected to a fictive duration of exactly 24 hours.</s><s>PVB were classified as ventricular or supraventricular in origin, and they were ranked as a singlet, couplet, triplet, or run.</s><s>A run was defined as more than 3 PVBs in a row.</s><s>All patients received identical loop recorders with telemedicine capabilities (Reveal XT; Medtronic).</s><s>Immediately before the surgical procedure, patients were screened for an eligible implant position in the body with the vendor-supplied dermal ECG vector measurement tool.</s><s>All patients showed good signal quality at the parasternal left position.</s><s>After aseptic preparation and local anesthesia, an incision approximately 3 cm long was made parasternal left.</s><s>Then, a subfascial pouch 8 to 10 cm long in the caudal direction was prepared with blunt dissection.</s><s>The Reveal device was inserted and fixed by muscular ligation with Mersilene.</s><s>The incision was closed with Vicryl subcutan and Prolene intracutan.</s><s>Then, the device was interrogated and activated with the external programmer.</s><s>Directly after the implantation procedure, the settings were programmed according to the study specifications (fast ventricular tachycardia: detection: on; ECG recording: on; interval: 290 ms, 30/40 beats; VT: detection: on; ECG recording: on; interval: 370 ms, 16 beats; asystole: detection: on; ECG recording: on; bradycardia: detection: on; ECG recording: on; interval: 1,500 ms, 4 beats; symptoms: detection: on; ECG recording: 3 episodes e 7.5 minutes; atrial tachycardia/AF: detection: on; ECG recording: on -all episodes).</s><s>All patients received a corresponding transmitter.</s><s>We requested that they should transfer data daily, whenever possible.</s><s>Transmitted data were interrogated at the study center daily (on workdays) through an electronic internet platform.</s></p><p><s>Continuous data are presented as the mean (SD); categorical variables are presented as numbers (percentages).</s><s>Categorical data were compared across groups with the chisquare test.</s><s>A 2-tailed probability value &lt;0.05 was considered significant.</s><s>Statistical analysis was performed with IBM SPSS, version 22 for Windows (SPSS, IBM, Chicago, Illinois).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Table <ref type="table" target="#tab_0">1</ref> lists the genetic and clinical data for every individual patient and information about their typical Fabry organ involvement.</s><s>Fifteen patients had a classical mutation, and one patient had a late-onset mutation, which typically presents as a cardiac variant.</s><s>Most patients were men (75%), and all had markedly elevated levels of globotriaosylsphingosine (Lyso-Gb3; mean 36.3</s><s>AE 32 ng/ml).</s><s>The mean age was 52 AE 11 years, and all were on enzyme replacement therapy for at least 2 years.</s><s>All patients submitted the data regularly, at a rate of 14 AE 11 times per month.</s><s>After device implantation, patients were prospectively followed with telemedicine for a median of 1.2 years (range 0.3 to 2.0 years), and no patient died during follow-up.</s></p><p><s>In Table <ref type="table" target="#tab_1">2</ref>, all individual echocardiographic and cMRI data are shown with the average values.</s><s>All patients showed LV hypertrophy (IVSd !11 mm), and all but one had visible papillary muscle thickening.</s><s>One patient had a reduced ejection fraction.</s><s>Seven patients had an E/E 0 above 15, which suggested elevated diastolic filling pressure.</s><s>The global systolic strain averaged À13 AE 5%, and systolic strain in the basal lateral wall was markedly reduced to À9AE6%, a sign of both reduced regional LV function and replacement fibrosis in loco typico.</s></p><p><s>Three patients did not receive cMRIs, due to claustrophobia; one was not eligible due to terminal renal insufficiency/dialysis.</s><s>All patients with cMRIs (n ¼ 12) showed replacement fibrosis in loco typico.</s><s>All patients who did not receive cMRIs had visible and quantifiable thinning of the posterior wall (defined as LV posterior wall thickness at end diastole !2 mm thinner than the IVSd).</s><s>Figure <ref type="figure" target="#fig_0">1</ref> shows representative examples of echocardiography and cMRI.</s></p><p><s>Table <ref type="table" target="#tab_2">3</ref> lists the results from the ECGs at rest.</s><s>Only 2 patients had a prolonged QTc interval.</s><s>Seven patients had a positive LV Sokolov index for LV hypertrophy, and 11 patients had T negativities in V5 and V6. Figure <ref type="figure" target="#fig_0">1</ref> shows a typical ECG at rest.</s></p><p><s>All patients were in sinus rhythm for both the resting and Holter ECG recordings.</s><s>During the Holter ECG, the mean heart rate was 68 AE 10 during the day and 57 AE 6 during the night.</s><s>No relevant bradycardia or VT was detected.</s><s>Three patients had ventricular runs for &lt;10 beats.</s><s>Eight patients had supraventricular runs with maximums of &lt;25 beats.</s></p><p><s>Table <ref type="table" target="#tab_3">4</ref> lists all the clinically relevant events recorded.</s><s>Three male patients had a documented asystole that prompted a recommendation for pacing therapy.</s><s>One patient experienced syncope, one experienced dizziness, and the third patient had no noticeable symptoms.</s><s>Because these 3 patients had also at least one VT documented with the event recorder, the final recommendation was an ICD implant, which had an implemented pacing function.</s><s>One female patient experienced 6 events of asystole, and the longest electrical ventricular pause lasted 3.4 seconds.</s><s>Because she was completely asymptomatic, she was not scheduled for a device implantation; instead, she received a careful watch and wait regime.</s><s>Figure <ref type="figure" target="#fig_1">2</ref> shows typical recordings for 2 patients with asystole.</s></p><p><s>One male patient experienced several episodes of symptomatic bradycardia; thus, pacemaker implantation was recommended.</s><s>One male patient experienced bradycardia of 26 beats/min, and he experienced syncope.</s><s>Because this patient had severe cardiac hypertrophy and a large area of fibrosis (3.21% of the LV), a prophylactic ICD was recommended.</s><s>In another male patient who had been taking a b blocker, we detected one asymptomatic bradycardia of 27 beats/min.</s><s>The recommendation for this patient was termination of beta-blocker therapy.</s><s>In addition, 4 patients (1 woman and 3 men) had several documented episodes of asymptomatic bradycardia.</s><s>Based on these events, a careful watch and wait regime was recommended.</s><s>However, later, 3 of these patients (all men) had a documented VT; thus, an ICD was recommended.</s><s>Figure <ref type="figure" target="#fig_1">2</ref> shows typical intracardiac electrograms (IEGMs) from 2 patients with bradycardia.</s></p><p><s>In 3 male and 2 female patients, the loop recorder documented intermittent asymptomatic AF that lasted at least 3 minutes.</s><s>Because all 5 patients had hypertrophic cardiomyopathy, therapeutic anticoagulation was recommended.</s><s>Figure <ref type="figure" target="#fig_2">3</ref> shows typical IEGM data from 2 patients with intermittent AF.</s><s>VTs were documented in 4 male patients.</s><s>Of these, 3 had sustained VTs, with syncope in one, chest pain in another, and no symptoms in the third; accordingly, ICDs were recommended.</s><s>The fourth patient had 2 nonsustained asymptomatic VTs, and the longer episode lasted 16 seconds at a heart rate of 200 beats/min.</s><s>This patient also  presented with episodes of bradycardia, which suggested a pacing indication.</s><s>Therefore, the final decision was to implant an ICD.</s><s>In addition, one female patient had an asymptomatic nonsustained VT, which lasted 4 seconds.</s><s>In this patient, a careful watch and wait regime was recommended.</s><s>Figure <ref type="figure" target="#fig_2">3</ref> shows typical IEGM examples from 2 patients with VTs.</s><s>When comparing clinically relevant events and the evaluated general and cardiomyopathy parameters, no significant correlation for any parameter was detected in these patients who were by the definition of inclusion criteria advanced cardiomyopathies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>It is well established that patients with Fabry disease can develop clinically relevant arrhythmias; in addition, most die due to cardiac complications. <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b13">13</ref></s><s>However, no previous study has systematically investigated both the frequency and the kind of arrhythmias in patients at risk.</s><s>The present prospective study focused on detecting relevant arrhythmias that could change clinical management in patients with advanced Fabry cardiomyopathy.</s><s>Our main findings were:</s></p><p><s>(1) modern technology has made it feasible to provide permanent telemonitoring for all types of arrhythmias; (2) a high number of clinically relevant arrhythmias were detected over time in Fabry hearts with advanced replacement fibrosis, despite negative results from an initial Holter ECG;</s></p><p><s>(3) we found both supraventricular and ventricular arrhythmias; consequently, a specific treatment was necessary in most patients to prevent stroke, syncope, and sudden cardiac death.</s></p><p><s>14e16 The present study focused on patients with Fabry disease that showed either a direct sign of replacement fibrosis (2 LE positive segments) or an indirect sign of severe fibrosis (regional wall motion abnormalities in the posterolateral wall).</s><s>The presence of fibrosis was the main inclusion criterion, because a recent study showed a close correlation between the burden of fibrosis and malignant arrhythmias in patients with Fabry cardiomyopathy. <ref type="bibr" target="#b8">9</ref></s><s>n these patients, considered at risk, careful monitoring is desirable.</s><s>An implantable loop recorder, such as the Reveal XT device, is an expedient tool for permanent telemonitoring. <ref type="bibr" target="#b9">10</ref></s><s>By transmitting all detected arrhythmias through telephone to the Fabry center, it was possible to securely diagnose, and subsequently, treat all relevant arrhythmias.</s><s>The loop recorder detected different types of supraventricular arrhythmias, including AF, bradycardia, and sinus arrest.</s><s>Although all patients had sinus rhythm at baseline (an inclusion criterion), the E/E 0 was above 10 in all patients, which suggested elevated LA pressure.</s><s>In addition, LA size was increased in a lot of patients.</s><s>Consistent with clinical experience, it was not surprising to find that a dilated LA with increased pressure was vulnerable to supraventricular arrhythmias.</s><s>17e19 More dangerous than atrial arrhythmias, we frequently detected ventricular arrhythmias, such as nonsustained and sustained VTs, in patients considered at risk.</s><s>Interestingly, none of the patients with a documented VT exhibited prolonged QT intervals on the ECG at rest.</s><s>Although all these patients with VT had myocardial fibrosis, based on the inclusion criteria, they did not have the largest volumes of fibrosis.</s><s>Thus, neither the ECG at rest nor the total quantities of fibrosis were good predictors for the VTs later documented.</s><s>When asked, only 1 patient reported that he experienced syncope during the VT.</s><s>Thus, it seemed clear that many potentially life-threatening arrhythmias are not recognized by patients with progressive Fabry disease.</s><s>The exact origin of these VTs remains an open question.</s><s>Recent studies in ischemic and dilated cardiomyopathy have shown that the presence of midventricular LE/fibrosis was closely associated with the development of VTs.</s><s>That finding suggested that these tachycardias are often generated at the border zone of myocardial fibrosis or a scar.</s><s>20e22 Thus, it can be speculated that the VTs may originate at the basal posterolateral wall, where cMRI data indicated that all patients had replacement fibrosis; consequently, progressive fibrosis visualized with MRI may be an indicator of generalized electrical instability of the heart.</s><s>In this study, all patients with a sustained VT received an implanted ICD for primary prophylaxis of sudden cardiac death.</s></p><p><s>Current guidelines for managing patients with Fabry recommend an annual Holter ECG. 9 However, our results suggested that the Holter ECG might not be sufficient for patients at risk.</s><s>Instead, in patients with severe Fabry cardiomyopathy, continuous surveillance with an implanted loop recorder and telemonitoring should be preferred.</s></p><p><s>Stroke is also a very common clinical event in patients with early and advanced Fabry. <ref type="bibr" target="#b24">23,</ref><ref type="bibr" target="#b25">24</ref></s><s>Our data confirmed that many patients with advanced cardiomyopathy develop intermittent AF, which may explain the potential for thromboembolic stroke.</s><s>Thus, in patients at risk, a thorough search for AF should be performed, and in case of a positive finding, therapeutic anticoagulation should be discussed.</s></p><p><s>The worst clinical event in Fabry disease is sudden cardiac death, which has been described as a major factor in the diminished life expectancy of these patients. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b26">25</ref></s><s>The present study confirmed previous studies, <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b13">13</ref> which showed that patients with advanced cardiomyopathy frequently develop VT.</s><s>Based on other forms of hypertrophic cardiomyopathy, it is well known that rhythm events, such as VT and ventricular fibrillation, are primarily responsible for sudden cardiac death. <ref type="bibr" target="#b17">17</ref></s><s>This suggests that, whenever a sustained VT is documented in a patient with Fabry, an ICD should be discussed.</s><s>Further studies must determine whether this intervention will effectively prolong life expectancy in these patients.</s></p><p><s>This prospective study focused on detecting clinically relevant arrhythmias.</s><s>Thus, we did not primarily aim to investigate advanced pharmaceutical and device-related therapy for arrhythmias in patients with Fabry.</s></p><p><s>Although 120 Fabry patients were screened, the total number of patients included in the present study was relatively low.</s><s>This was because we only included patients with very advanced Fabry cardiomyopathy.</s><s>Because large numbers of events were detected in most of the selected patients, despite negative initial 12-channel and Holter ECGs, we speculated that the inclusion criteria may have been too strict.</s><s>In this context, it is very interesting that in these advanced cardiomyopathy hearts, no significant correlation for any parameter with the events was detected, even not for the gender.</s><s>Thus, further studies should use an implanted loop recorder to focus on the earlier stages of Fabry cardiomyopathy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosures</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Example of a 45-year-old male patient with typical, advanced Fabry cardiomyopathy.</s><s>In this patient, bradycardia, asystole, intermittent AF, and sustained VT were detected with an implanted loop recorder.</s><s>Left (A): representative echocardiography from a parasternal long-axis viewpoint shows eccentric hypertrophic cardiomyopathy.</s><s>Right top (B): representative cardiac magnetic resonance image in the short-axis orientation.</s><s>The red arrow indicates a large area with positive LE, which indicates replacement fibrosis.</s><s>Right bottom (C): 12-lead, resting electrocardiograph with signs of LV hypertrophy in advanced Fabry cardiomyopathy.</s><s>EF ¼ ejection fraction; hs-TNT ¼ highly sensitive troponin; LV ¼ left ventricle; LVPWd ¼ left ventricular posterior wall thickness at end diastole; NT-proBNP ¼ N-terminal propeptid of the brain natriuretic peptide.</s></p></div></figDesc><graphic coords="6,96.66,65.25,382.68,293.39" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Examples of arrhythmias detected in patients with Fabry who received an implanted loop recorder.</s><s>ECGs show: (A) 2 patients with asystole and (B) 2 patients with bradycardia.</s><s>EF ¼ ejection fraction; HR ¼ heart rate; hs-TNT ¼ highly sensitive troponin; LV ¼ left ventricle; LVPWd ¼ left ventricular posterior wall thickness at end diastole; NT-proBNP ¼ N-terminal propeptid of the brain natriuretic peptide.</s></p></div></figDesc><graphic coords="8,39.74,65.25,496.46,552.93" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Examples of arrhythmias detected in patients with Fabry who received an implanted loop recorder.</s><s>ECGs show: (A) 2 patients with intermittent AF and (B) 2 patients with VT.</s><s>EF ¼ ejection fraction; HR ¼ heart rate; hs-TNT ¼ highly sensitive troponin; LV ¼ left ventricle; LVPWd ¼ left ventricular posterior wall thickness at end diastole; NT-proBNP ¼ N-terminal propeptid of the brain natriuretic peptide.</s></p></div></figDesc><graphic coords="9,39.91,65.25,496.27,542.55" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Baseline characteristics of all Fabry patients</s></p></div></figDesc><table><row><cell>Patient</cell><cell>Genetics</cell><cell>Age</cell><cell cols="2">Sex Height</cell><cell>Weight</cell><cell>Gal-A activation</cell><cell>lysoGb3</cell><cell>ERT for</cell><cell>Kidney</cell><cell>Dialysis</cell><cell>GFR (MDRD)</cell><cell cols="3">TIA/Stroke* Dyshidrosis Angiokeratoma</cell></row><row><cell>number</cell><cell></cell><cell>(years)</cell><cell></cell><cell>(cm)</cell><cell>(kg)</cell><cell>(nmol/min/mg)</cell><cell>(ng/ml)</cell><cell>(years)</cell><cell>TX</cell><cell></cell><cell>(ml/min/1.73 m 2 )</cell><cell></cell><cell></cell><cell></cell></row><row><cell>1</cell><cell>Exon7. Mutation E341 K</cell><cell>53</cell><cell>M</cell><cell>185</cell><cell>57</cell><cell>0.03</cell><cell>63.1</cell><cell>10</cell><cell>0</cell><cell>0</cell><cell>83</cell><cell>þ</cell><cell>þ</cell><cell>þ</cell></row><row><cell>2</cell><cell>Exon 7. Del c.1221 delA</cell><cell>58</cell><cell>F</cell><cell>163</cell><cell>56</cell><cell>0.14</cell><cell>18.7</cell><cell>3</cell><cell>0</cell><cell>0</cell><cell>55</cell><cell>0</cell><cell>0</cell><cell>0</cell></row><row><cell>3</cell><cell>Exon3. Mutation D136 E</cell><cell>70</cell><cell>F</cell><cell>165</cell><cell>71</cell><cell>0.15</cell><cell>11.2</cell><cell>10</cell><cell>0</cell><cell>0</cell><cell>76</cell><cell>0</cell><cell>0</cell><cell>0</cell></row><row><cell>4</cell><cell>Intron 3. IVS3þ1 G &gt; A</cell><cell>45</cell><cell>M</cell><cell>184</cell><cell>75</cell><cell>0.04</cell><cell>21.2</cell><cell>12</cell><cell>þ</cell><cell>0</cell><cell>4 7</cell><cell>0</cell><cell>þ</cell><cell>0</cell></row><row><cell>5</cell><cell>Exon 7. Mutation E341 K</cell><cell>49</cell><cell>M</cell><cell>180</cell><cell>72</cell><cell>0.02</cell><cell>65.7</cell><cell>11</cell><cell>0</cell><cell>0</cell><cell>110</cell><cell>0</cell><cell>þ</cell><cell>0</cell></row><row><cell>6</cell><cell>Exon7. Mutation c.1208.del</cell><cell>45</cell><cell>M</cell><cell>184</cell><cell>84</cell><cell>0.02</cell><cell>15.0</cell><cell>11</cell><cell>þ</cell><cell>þ</cell><cell>58</cell><cell>0</cell><cell>þ</cell><cell>þ</cell></row><row><cell>7</cell><cell>Exon 7. Deletion 354 fs Del 15 bp</cell><cell>54</cell><cell>F</cell><cell>165</cell><cell>64</cell><cell>0.19</cell><cell>10.1</cell><cell>9</cell><cell>0</cell><cell>0</cell><cell>82</cell><cell>0</cell><cell>þ</cell><cell>þ</cell></row><row><cell>8</cell><cell>Transition c664A &gt; G;</cell><cell>67</cell><cell>M</cell><cell>170</cell><cell>63</cell><cell>0.13</cell><cell>6.0</cell><cell>2</cell><cell>0</cell><cell>0</cell><cell>103</cell><cell>0</cell><cell>þ</cell><cell>þ</cell></row><row><cell></cell><cell>Mutation N215S</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>9</cell><cell>Exon 1. c.162 del T</cell><cell>54</cell><cell>M</cell><cell>177</cell><cell>78</cell><cell>0.08</cell><cell>30.6</cell><cell>13</cell><cell>þ</cell><cell>0</cell><cell>4 0</cell><cell>þ</cell><cell>þ</cell><cell>þ</cell></row><row><cell>10</cell><cell>Exon 7. Mutation c.1208 del</cell><cell>49</cell><cell>M</cell><cell>178</cell><cell>72</cell><cell>0.03</cell><cell>28.1</cell><cell>12</cell><cell>0</cell><cell>0</cell><cell>85</cell><cell>0</cell><cell>þ</cell><cell>0</cell></row><row><cell>11</cell><cell>Exon 1. C134T &gt; C [L45P]</cell><cell>36</cell><cell>M</cell><cell>193</cell><cell>83</cell><cell>0</cell><cell>63.4</cell><cell>3</cell><cell>0</cell><cell>0</cell><cell>100</cell><cell>þ</cell><cell>þ</cell><cell>0</cell></row><row><cell>12</cell><cell>Exon 3. Mutation D136 E</cell><cell>48</cell><cell>M</cell><cell>182</cell><cell>83</cell><cell>0.02</cell><cell>15.1</cell><cell>11</cell><cell>þ</cell><cell>0</cell><cell>7 4</cell><cell>0</cell><cell>þ</cell><cell>0</cell></row><row><cell>13</cell><cell>Intron 6 Trans IVS6-10G</cell><cell>36</cell><cell>M</cell><cell>187</cell><cell>86</cell><cell>0.04</cell><cell>30.3</cell><cell>2</cell><cell>0</cell><cell>0</cell><cell>80</cell><cell>0</cell><cell>0</cell><cell>þ</cell></row><row><cell></cell><cell>&gt; A Splice-Site-Mutation</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Mut c.1000-10G &gt; A</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>14</cell><cell>Exon 6. c. 973 G &gt; A</cell><cell>73</cell><cell>F</cell><cell>156</cell><cell>52</cell><cell>0.23</cell><cell>7.2</cell><cell>3</cell><cell>0</cell><cell>0</cell><cell>39</cell><cell>0</cell><cell>0</cell><cell>0</cell></row><row><cell></cell><cell>Mutation G325S</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>15</cell><cell>c.747A &gt; G</cell><cell>56</cell><cell>M</cell><cell>170</cell><cell>60</cell><cell>0.03</cell><cell>74.7</cell><cell>2</cell><cell>0</cell><cell>0</cell><cell>102</cell><cell>0</cell><cell>0</cell><cell>þ</cell></row><row><cell>16</cell><cell>c.982 G &gt; C</cell><cell>43</cell><cell>M</cell><cell>148</cell><cell>68</cell><cell>0.02</cell><cell>114</cell><cell>4</cell><cell>0</cell><cell>0</cell><cell>116</cell><cell>0</cell><cell>0</cell><cell>þ</cell></row></table><note><p><s>ERT ¼ enzyme replacement therapy; F ¼ female; GFR ¼ glomerula filtration rate; M ¼ male; TIA ¼ transistoric ischemic attack; TX ¼ transplantation.</s><s>* All TIA and stroke were not due to documented atrial fibrillation.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>LVMI ¼ left ventricular mass index; LVSd ¼ left ventricular systolic diameter; LVPWd ¼ left ventricular posterior wall thickness at diastole; IVSd ¼ interventricular septal wall thickness at diastole; NA ¼ not available.</s></p></div></figDesc><table><row><cell>Organ specific values</cell><cell></cell></row><row><cell>Patient</cell><cell>Echocardiography</cell></row><row><cell>number</cell><cell></cell></row></table><note><p><s>AO ¼ aortic; DT ¼ deceleration time; EF ¼ ejection fraction; LV ¼ left ventricular; LVDd ¼ left ventricular diastolic diameter; LVED ¼ left ventricular end-diastolic; LVES ¼ left ventricular end-systolic;</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 Electrocardiography</head><label>3</label><figDesc></figDesc><table><row><cell cols="2">Patient number Heart</cell><cell>Heart axis</cell><cell>Heart rate</cell><cell>P-dur.</cell><cell cols="3">PQ dur. (ms) QRS dur. (ms) QTc dur. (ms)</cell><cell>Sokolow</cell><cell>T-wave</cell><cell>ST elevation</cell></row><row><cell></cell><cell>rhythm</cell><cell></cell><cell>(min À1 )</cell><cell>time (ms)</cell><cell></cell><cell></cell><cell></cell><cell>index (þ/0)</cell><cell>negativity (þ/0)</cell><cell>(þ/0)</cell></row><row><cell>1</cell><cell>SR</cell><cell>Vertical</cell><cell>56</cell><cell>100</cell><cell>120</cell><cell>130</cell><cell>425</cell><cell>þ</cell><cell>þ</cell><cell>0</cell></row><row><cell>2</cell><cell>SR</cell><cell>Intermediate</cell><cell>54</cell><cell>80</cell><cell>100</cell><cell>100</cell><cell>588</cell><cell>þ</cell><cell>þ</cell><cell>0</cell></row><row><cell>3</cell><cell>SR</cell><cell>Intermediate</cell><cell>68</cell><cell>80</cell><cell>120</cell><cell>80</cell><cell>383</cell><cell>0</cell><cell>þ</cell><cell>0</cell></row><row><cell>4</cell><cell>SR</cell><cell>Intermediate</cell><cell>64</cell><cell>100</cell><cell>150</cell><cell>100</cell><cell>427</cell><cell>þ</cell><cell>0</cell><cell>0</cell></row><row><cell>5</cell><cell>SR</cell><cell>Intermediate</cell><cell>64</cell><cell>100</cell><cell>120</cell><cell>100</cell><cell>392</cell><cell>0</cell><cell>0</cell><cell>0</cell></row><row><cell>6</cell><cell>SR</cell><cell>Intermediate</cell><cell>52</cell><cell>100</cell><cell>140</cell><cell>90</cell><cell>400</cell><cell>þ</cell><cell>0</cell><cell>0</cell></row><row><cell>7</cell><cell>SR</cell><cell>Intermediate</cell><cell>50</cell><cell>110</cell><cell>140</cell><cell>120</cell><cell>420</cell><cell>þ</cell><cell>þ</cell><cell>0</cell></row><row><cell>8</cell><cell>SR</cell><cell>Left</cell><cell>52</cell><cell>80</cell><cell>160</cell><cell>130</cell><cell>437</cell><cell>0</cell><cell>þ</cell><cell>0</cell></row><row><cell>9</cell><cell>SR</cell><cell>Intermediate</cell><cell>91</cell><cell>90</cell><cell>110</cell><cell>100</cell><cell>394</cell><cell>þ</cell><cell>þ</cell><cell>0</cell></row><row><cell>10</cell><cell>SR</cell><cell>Intermediate</cell><cell>78</cell><cell>80</cell><cell>80</cell><cell>100</cell><cell>388</cell><cell>0</cell><cell>0</cell><cell>0</cell></row><row><cell>11</cell><cell>SR</cell><cell>Intermediate</cell><cell>52</cell><cell>110</cell><cell>180</cell><cell>120</cell><cell>382</cell><cell>þ</cell><cell>0</cell><cell>0</cell></row><row><cell>12</cell><cell>SR</cell><cell>Left</cell><cell>72</cell><cell>100</cell><cell>110</cell><cell>110</cell><cell>427</cell><cell>0</cell><cell>þ</cell><cell>0</cell></row><row><cell>13</cell><cell>SR</cell><cell>Left</cell><cell>54</cell><cell>100</cell><cell>110</cell><cell>100</cell><cell>379</cell><cell>0</cell><cell>þ</cell><cell>0</cell></row><row><cell>14</cell><cell>SR</cell><cell>Left</cell><cell>58</cell><cell>100</cell><cell>160</cell><cell>160</cell><cell>492</cell><cell>0</cell><cell>þ</cell><cell>0</cell></row><row><cell>15</cell><cell>SR</cell><cell>Intermediate</cell><cell>64</cell><cell>90</cell><cell>150</cell><cell>110</cell><cell>434</cell><cell>0</cell><cell>þ</cell><cell>0</cell></row><row><cell>16</cell><cell>SR</cell><cell>Intermediate</cell><cell>80</cell><cell>80</cell><cell>130</cell><cell>100</cell><cell>439</cell><cell>0</cell><cell>þ</cell><cell>0</cell></row><row><cell>Mean</cell><cell></cell><cell></cell><cell>63AE12</cell><cell>95AE11</cell><cell>130AE26</cell><cell>109AE19</cell><cell>426AE53</cell><cell cols="2">þ¼7(44%) þ¼11(67%)</cell><cell>þ¼0 (0%)</cell></row></table><note><p><s>Dur ¼ duration; SR ¼ sinus rhythm.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4</head><label>4</label><figDesc><div><p><s>Events detected by implantable loop recorder separated for clinical relevance (¼ changing therapy, n ¼ 15) and irrelevance (¼ watch and wait, n ¼ 6)</s></p></div></figDesc><table><row><cell>Event: Asystole</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Patient number</cell><cell>Numbers</cell><cell>Type of Event</cell><cell>Max. duration (sec)</cell><cell>Time</cell><cell>Recommendation</cell></row><row><cell>6</cell><cell>4x</cell><cell>Asystole</cell><cell>3.7</cell><cell>6-9 am</cell><cell>ICD-Implantation*</cell></row><row><cell>4</cell><cell>3x</cell><cell>Asystole</cell><cell>3.3</cell><cell>10 pm-9am</cell><cell>ICD-Implantation*</cell></row><row><cell>1</cell><cell>53x</cell><cell>Asystole</cell><cell>4.4</cell><cell>10 pm-12 am</cell><cell>ICD-Implantation*</cell></row><row><cell>2</cell><cell>6x</cell><cell>Asystole</cell><cell>3.3</cell><cell>10 pm-6am</cell><cell>Watch and wait</cell></row><row><cell>Event: Bradycardia</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Patient number</cell><cell>Numbers</cell><cell>Event</cell><cell>Min. frequency (1/min)</cell><cell>Time</cell><cell>Recommendation</cell></row><row><cell>5</cell><cell>19x</cell><cell>Bradycardia</cell><cell>39</cell><cell>10 pm-12 am</cell><cell>Pacemaker-Implantation</cell></row><row><cell>9</cell><cell>1x</cell><cell>Bradycardia</cell><cell>27</cell><cell>6-9 am</cell><cell>Termination of b-Blockers</cell></row><row><cell>16</cell><cell>1x</cell><cell>Bradycardia</cell><cell>26</cell><cell>9-12 am</cell><cell>ICD-Implantation  †</cell></row><row><cell>3</cell><cell>1x</cell><cell>Bradycardia</cell><cell>54</cell><cell>10 pm-6 am</cell><cell>Watch and wait</cell></row><row><cell>4</cell><cell>&gt;1700x</cell><cell>Bradycardia</cell><cell>37</cell><cell>10 pm-9 am</cell><cell>Watch and wait</cell></row><row><cell>6</cell><cell>&gt;1400x</cell><cell>Bradycardia</cell><cell>38</cell><cell>9 pm-12 am</cell><cell>Watch and wait</cell></row><row><cell>8</cell><cell>&gt;5000x</cell><cell>Bradycardia</cell><cell>36</cell><cell>10 pm-9 am</cell><cell>Watch and wait</cell></row><row><cell>Event: Atrial Fibrillation</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Patient number</cell><cell>Event</cell><cell></cell><cell>Max. frequency (1/min)</cell><cell>Max. time (sec)</cell><cell>Recommendation</cell></row><row><cell>1</cell><cell cols="2">Intermittent AF</cell><cell>46</cell><cell>&gt;85000</cell><cell>Anticoagulation</cell></row><row><cell>3</cell><cell cols="2">Intermittent AF</cell><cell>105</cell><cell>7200</cell><cell>Anticoagulation</cell></row><row><cell>6</cell><cell cols="2">Intermittent AF</cell><cell>103</cell><cell>1560</cell><cell>Anticoagulation</cell></row><row><cell>4</cell><cell cols="2">Intermittent AF</cell><cell>120</cell><cell>240</cell><cell>Anticoagulation</cell></row><row><cell>7</cell><cell cols="2">Intermittent AF</cell><cell>122</cell><cell>1560</cell><cell>Anticoagulation</cell></row><row><cell cols="2">Event: Ventricular Tachycardia</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Patient number</cell><cell>Numbers</cell><cell>Event</cell><cell>Max. frequency (1/min)</cell><cell>Max. time (sec)</cell><cell>Recommendation</cell></row><row><cell>1</cell><cell>3x</cell><cell>VT</cell><cell>188</cell><cell>48</cell><cell>ICD-Implantation</cell></row><row><cell>4</cell><cell>5x</cell><cell>VT</cell><cell>200</cell><cell>360</cell><cell>ICD-Implantation</cell></row><row><cell>6</cell><cell>2x</cell><cell>VT</cell><cell>200</cell><cell>16</cell><cell>ICD-Implantation</cell></row><row><cell>8</cell><cell>3x</cell><cell>VT</cell><cell>206</cell><cell>45</cell><cell>ICD-Implantation</cell></row><row><cell>3</cell><cell>1x</cell><cell>VT</cell><cell>200</cell><cell>4</cell><cell>Watch and wait</cell></row><row><cell cols="4">AF ¼ atrial fibrillation; ICD ¼ implantable cardioverteredefibrillator; VT ¼ ventricular tachycardia.</cell><cell></cell><cell></cell></row><row><cell cols="3">* Because of additional ventricular tachycardia.</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>†Because of large area of fibrosis.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head></head><label></label><figDesc><div><p><s>Drs. Weidemann, Canan-Kühl, and Wanner received speaker honoraria from Genzyme and from Shire Corporation.</s><s>Drs.</s><s>Weidemann and Wanner are members of the Fabry Registry European Board of Advisors and have received travel assistance and speaker honoraria.</s><s>Research grants were given to the Institution by Genzyme and Shire Corporations.</s><s>Drs.</s><s>Maier and Becher received speaker honoraria and research funding from Medtronic GmbH, Germany.</s><s>The other authors have no conflicts of interest to disclose.</s></p></div></figDesc><table /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Cardiomyopathy/Serious Arrhythmias in Fabry Cardiomyopathy</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">The American Journal of Cardiology (www.ajconline.org)</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Fabry disease, an underrecognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Desnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Barranger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Germain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grabowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Packman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Wilcox</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="338" to="e346" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sachdev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Elkington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Mckenna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Pennell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Leed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Elliott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="2151" to="e2155" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Natural course of Fabry disease: changing pattern of causes of death in FOS -Fabry Outcome Survey</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Giugliani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Linhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sunder-Plassmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="548" to="e552" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry</title>
		<author>
			<persName><forename type="first">S</forename><surname>Waldek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Banikazemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lemay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genet Med</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="790" to="e796" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sheppard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Reed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Pennell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Magn Reson</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="479" to="e482" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease</title>
		<author>
			<persName><forename type="first">F</forename><surname>Weidemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breunig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sandstede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Voelker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ertl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Knoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Strotmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1221" to="e1227" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">A new echocardiographic approach for the detection of nonischaemic fibrosis in hypertrophic myocardium</title>
		<author>
			<persName><forename type="first">F</forename><surname>Weidemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Niemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Herrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Waller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breunig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Voelker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ertl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bijnens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Strotmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="3020" to="e3026" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Niemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Frantz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ertl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Weidemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="895" to="e900" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Fabry disease: guidelines for the evaluation and management of multi-organ system involvement</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Eng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Germain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Banikazemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Warnock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Hopkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bultas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sims</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Brodie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Pastores</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Strotmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Wilcox</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genet Med</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="539" to="e548" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT trial</title>
		<author>
			<persName><forename type="first">G</forename><surname>Hindricks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pokushalov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Urban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Taborsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Kuck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lebedev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rieger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Purerfellner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Arrhythm Electrophysiol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="141" to="e147" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>January</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Wann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Alpert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Calkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Cigarroa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Cleveland</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Conti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Ellinor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Ezekowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Field</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Sacco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Stevenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Tchou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Tracy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Yancy</surname></persName>
		</author>
		<title level="m">AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology</title>
				<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">American Heart Association task force on practice guidelines and the Heart Rhythm Society</title>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="e199" to="e267" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for devicebased therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Epstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Dimarco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Ellenbogen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Estes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Freedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Gettes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Gillinov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gregoratos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Hammill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Hlatky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Newby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Page</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Schoenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Silka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Stevenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Sweeney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart Rhythm Society. Circulation</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="e283" to="e352" />
			<date type="published" when="2012">2012. 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sachdev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tome</forename><forename type="middle">M</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="842" to="e846" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment</title>
		<author>
			<persName><forename type="first">M</forename><surname>Niemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Herrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breunig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Strotmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Machann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Voelker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ertl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Weidemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JACC Cardiovasc Imaging</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="592" to="e601" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The Fabry cardiomyopathy -diagnostic approach and current treatment</title>
		<author>
			<persName><forename type="first">F</forename><surname>Weidemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ertl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kramer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Pharm Des</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="473" to="e478" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment</title>
		<author>
			<persName><forename type="first">F</forename><surname>Weidemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Niemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breunig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Herrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Voelker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ertl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Strotmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="524" to="e529" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Anastasakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Borger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Borggrefe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cecchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Charron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Hagege</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lafont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Limongelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mahrholdt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Mckenna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mogensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nihoyannopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nistri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Pieper</surname></persName>
		</author>
		<title level="m">ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology</title>
				<meeting><address><addrLine>Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H</addrLine></address></meeting>
		<imprint>
			<publisher>ESC</publisher>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="2733" to="e2779" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association task force on practice guidelines</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Wann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Curtis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Ellenbogen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Estes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Ezekowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Jackman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>January</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Lowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Page</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Slotwiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Stevenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Tracy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fuster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Ryden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Cannom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Crijns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Halperin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Heuzey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Olsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Prystowsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Tamargo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<date type="published" when="2013">2013. 1916e1926</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">R</forename><surname>Coelho-Filho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Lakdawala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Cirino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jarolim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kwong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gonzalez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Colan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Seidman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Diez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Seidman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="page" from="552" to="e563" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">Y</forename><surname>Kwong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Reynolds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="2733" to="e2743" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Assomull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Burman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Sheppard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Poole-Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Pennell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<date type="published" when="2006">2006. 1977e1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Carroll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Murday</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Peebles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Harden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Curzen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Arrhythm Electrophysiol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="324" to="e330" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Cerebrovascular involvement in Fabry disease: current status of knowledge</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kolodny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fellgiebel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Hilz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sims</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Caruso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Phan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Politei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Manara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Burlina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="302" to="e313" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Acute cerebrovascular disease in the young: the stroke in young Fabry patients study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rolfs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fazekas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Grittner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dichgans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Martus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Holzhausen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bottcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">U</forename><surname>Heuschmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tatlisumak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tanislav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Jungehulsing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Giese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Putaala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Bodechtel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lichy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Enzinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Hennerici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kaps</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lackner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Paschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mascher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Riess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kolodny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Norrving</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="340" to="e349" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Outcomes of patients treated through the Canadian Fabry disease initiative</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Sirrs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Bichet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Casey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lemoine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Doucette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>West</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Genet Metab</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="499" to="e506" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
